| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 5, 2735-2739, Copyright © 1991 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
RA Dean, CD Christian, RH Sample and WF Bosron
Department of Pathology, Indiana University School of Medicine, Indianapolis 46202-5122.
A new, pharmacologically active metabolite of cocaine, ethylcocaine, has been reported in individuals after concurrent use of cocaine and ethanol. Formation of ethylcocaine may contribute to the common coabuse of these two drugs and the apparent danger of this practice. We have identified a nonspecific carboxyl-esterase that catalyzes the ethyl transesterification of cocaine to ethylcocaine in the presence of ethanol. In the absence of ethanol, this human liver esterase catalyzes the hydrolysis of cocaine to benzoylecgonine, a metabolite that is inactive as a psychomotor stimulant. A second human liver esterase is also described. This enzyme catalyzes hydrolysis of cocaine to ecgonine methyl ester, also inactive as a stimulant. These two liver esterases may play important roles in regulating the metabolic inactivation of cocaine.
This article has been cited by other articles:
|
|
 |
|
  F. Schifano and J. Corkery Cocaine/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990 2004) J Psychopharmacol, January 1, 2008; 22(1): 71 - 79. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. Kreek, G. Bart, C. Lilly, K. S. Laforge, and D. A. Nielsen Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments Pharmacol. Rev., March 1, 2005; 57(1): 1 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tabata, M. Katoh, S. Tokudome, M. Nakajima, and T. Yokoi IDENTIFICATION OF THE CYTOSOLIC CARBOXYLESTERASE CATALYZING THE 5'-DEOXY-5-FLUOROCYTIDINE FORMATION FROM CAPECITABINE IN HUMAN LIVER Drug Metab. Dispos., October 1, 2004; 32(10): 1103 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. O'Leary, M. Digregorio, and M. Chahine Closing and Inactivation Potentiate the Cocaethylene Inhibition of Cardiac Sodium Channels by Distinct Mechanisms Mol. Pharmacol., December 1, 2003; 64(6): 1575 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Laizure, T. Mandrell, N. M. Gades, and R. B. Parker Cocaethylene Metabolism and Interaction with Cocaine and Ethanol: Role of Carboxylesterases Drug Metab. Dispos., January 1, 2003; 31(1): 16 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Xu, W. Zhang, M. K. Ma, and H. L. McLeod Human Carboxylesterase 2 Is Commonly Expressed in Tumor Tissue and Is Correlated with Activation of Irinotecan Clin. Cancer Res., August 1, 2002; 8(8): 2605 - 2611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E O'Leary Inhibition of HERG potassium channels by cocaethylene: a metabolite of cocaine and ethanol Cardiovasc Res, January 1, 2002; 53(1): 59 - 67. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Scheidweiler, J. Shojaie, M. A. Plessinger, R. W. Wood, and T. C. Kwong Stability of Methylecgonidine and Ecgonidine in Sheep Plasma in Vitro Clin. Chem., November 1, 2000; 46(11): 1787 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Carmona, R. A. Jufer, S. R. Goldberg, D. A. Gorelick, N. H. Greig, Q.-S. Yu, E. J. Cone, and C. W. Schindler Butyrylcholinesterase Accelerates Cocaine Metabolism: In Vitro and In Vivo Effects in Nonhuman Primates and Humans Drug Metab. Dispos., March 1, 2000; 28(3): 367 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Humerickhouse, K. Lohrbach, L. Li, W. F. Bosron, and M. E. Dolan Characterization of CPT-11 Hydrolysis by Human Liver Carboxylesterase Isoforms hCE-1 and hCE-2 Cancer Res., March 1, 2000; 60(5): 1189 - 1192. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Torres and J. M. Horowitz Drugs of Abuse and Brain Gene Expression Psychosom Med, September 1, 1999; 61(5): 630 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, J. C. Burnell, N. Dumaual, and W. F. Bosron Binding and Hydrolysis of Meperidine by Human Liver Carboxylesterase hCE-1 J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 314 - 318. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Bourland, D. K. Martin, and M. Mayersohn In Vitro Transesterification of Cocaethylene (Ethylcocaine) in the Presence of Ethanol. Esterase-Mediated Ethyl Ester Exchange Drug Metab. Dispos., March 1, 1998; 26(3): 203 - 206. [Abstract] [Full Text]
|
|
|
|
|
|
M. Farré, R. De La Torre, M. L. González, M. T. Terán, P. N. Roset, E. Menoyo, and J. Camí Cocaine and Alcohol Interactions in Humans: Neuroendocrine Effects and Cocaethylene Metabolism J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 164 - 176. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Brzezinski, B. J. Spink, R. A. Dean, C. E. Berkman, J. R. Cashman, and W. F. Bosron Human Liver Carboxylesterase hCE-1: Binding Specificity for Cocaine, Heroin, and their Metabolites and Analogs Drug Metab. Dispos., September 1, 1997; 25(9): 1089 - 1096. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. V. Pindel, N. Y. Kedishvili, T. L. Abraham, M. R. Brzezinski, J. Zhang, R. A. Dean, and W. F. Bosron Purification and Cloning of a Broad Substrate Specificity Human Liver Carboxylesterase That Catalyzes the Hydrolysis of Cocaine and Heroin J. Biol. Chem., June 6, 1997; 272(23): 14769 - 14775. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
